title: [Prognosis of repetitive excisions of bronchial cancer].
abstract: The indications for repeated excision for bronchial cancer may be raised in cases of a synchronous second (or subsequent cancer) or in the case of a local recurrence of the initial cancer which was operated upon. Ninety consecutive patients had a repeat operation for cancer over a 30 year period. There were 86 men and 4 women with a mean age of 59. The initial cancer had most often been treated with lobectomy or bilobectomy and was relatively localised (90% stage I or II). However, 7 patients had a pneumonectomy. The repeat operation was carried out for 30 recurrences and in 44 for secondary subsequent cancers and in 16 cases for a bilateral synchronous cancer. The second operative intervention led to 30 pneumonectomies, 29 lobectomies and 20 atypical excisions. On the otherhand 11 patients had an exploratory thoracotomy and on 10 occasions there was local regional recurrence. These secondary localisations were classified as 44 stage I, 9 stage II and 26 stage III. Eight patients had major loss of lung parenchyma with a pneumonectomy on one side and an atypical excision or a lobectomy on the other. Six patients (6.5%) died in the post-operative period (two from respiratory failure and two due to cardiovascular causes and two sepsis). The actual survival at 5 years was 20% in cases that had an excision. The prognosis was identical in cases having a resection for a recurrence or for secondary subsequent cancer or for bilateral synchronous cancers.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Service de Chirurgie Thoracique et Vasculaire, Hôpital Marie-Lannelongue, Le Plessis-Robinson.
authors.forename: J F
authors.initials: JF
authors.lastname: Regnard
authors.forename: P
authors.initials: P
authors.lastname: Icard
authors.forename: M
authors.initials: M
authors.lastname: Deneuville
authors.forename: P
authors.initials: P
authors.lastname: Dartevelle
authors.forename: P
authors.initials: P
authors.lastname: Levasseur
mesh_terms: D000206:Actuarial Analysis; D000359:Aftercare; D002283:Carcinoma, Bronchogenic / Q000453:epidemiology / Q000473:pathology / Q000601:surgery*; D002423:Cause of Death; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D009367:Neoplasm Staging; D016609:Neoplasms, Second Primary / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D011013:Pneumonectomy / Q000706:statistics & numerical data; D011379:Prognosis; D012086:Reoperation / Q000706:statistics & numerical data; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate; D013908:Thoracotomy / Q000706:statistics & numerical data
vernacular_title: Pronostic des exérèses itératives pour cancer bronchique.